Abstract
This monthly feature will help readers keep current on new drug, new indications, dosage forms and safety-related changes in labeling or use. Efforts have been made to assure the accuracy of this information; however, if there are any questions, please let us know at jgeneral@ku.edu. For this combined issue, a 2-month period is covered (April 16, 2016 through June 16, 2016).